KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $925.0 million.

  • Medtronic's Cash from Operations fell 344.47% to $925.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $7.1 billion, marking a year-over-year decrease of 113.97%. This contributed to the annual value of $7.0 billion for FY2025, which is 378.67% up from last year.
  • According to the latest figures from Q4 2025, Medtronic's Cash from Operations is $925.0 million, which was down 344.47% from $1.1 billion recorded in Q3 2025.
  • Over the past 5 years, Medtronic's Cash from Operations peaked at $2.8 billion during Q2 2024, and registered a low of $661.0 million during Q4 2023.
  • Moreover, its 5-year median value for Cash from Operations was $1.7 billion (2021), whereas its average is $1.7 billion.
  • As far as peak fluctuations go, Medtronic's Cash from Operations surged by 36474.82% in 2021, and later tumbled by 4788.02% in 2022.
  • Quarter analysis of 5 years shows Medtronic's Cash from Operations stood at $1.8 billion in 2021, then crashed by 47.88% to $922.0 million in 2022, then fell by 28.31% to $661.0 million in 2023, then soared by 44.93% to $958.0 million in 2024, then fell by 3.44% to $925.0 million in 2025.
  • Its Cash from Operations was $925.0 million in Q4 2025, compared to $1.1 billion in Q3 2025 and $2.5 billion in Q2 2025.